ELDN: Eledon Pharmaceuticals Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | New 13G stake | Vanguard Capital Management | 5.05% | SEC |
Institutional ownership (Q2 2026)
161 institutions reported holding $183.72M of Eledon Pharmaceuticals Inc on Form 13F (121 the quarter before). 49 opened a new position and 9 sold out. Shares held by institutions: +10%.
| Largest holders | Shares | Value |
|---|---|---|
| BVF INC/IL | 6,293,282 | $24.80M |
| BlackRock, Inc. | 5,123,842 | $20.19M |
| Defilade Capital Management, L.P. | 3,525,338 | $13.89M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,417,223 | $13.46M |
| GOLDMAN SACHS GROUP INC | 2,510,308 | $9.89M |
| Ensign Peak Advisors, Inc | 2,101,224 | $8.28M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,956,601 | $7.71M |
| Catalio Capital Management, LP | 1,695,071 | $6.68M |
| STATE STREET CORP | 1,621,969 | $6.39M |
| Zimmer Partners, LP | 1,596,599 | $6.29M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.